Market Research Analysis Biomarker Market Trends, Growth, Type and Share | страница 2

Driving factors responsible for the growth of biomarkers market include rise in diagnostic applications of biomarkers,
increase in R&D funding for biotech and pharma companies, rise in number of CROs and reasonable cost for clinical
trials in emerging economies. Also, the rising cases of cancer and initiatives for research and development add to the
market growth. However, the high capital investments and low proportion of cost-benefit coupled with minimal
government regulations and reimbursement systems and more probably the technical issues pertaining to collection
and storage are the major restraining factors responsible for the market.
Based on segmentation by product, the biomarker market includes services, software and consumables. Based on
segmentation by type, the biomarkers market includes safety biomarkers, efficacy biomarkers, predictive biomarkers,
surrogate biomarkers, pharmacodynamics biomarkers, prognostic biomarkers and validation biomarkers.
Get a Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/biomarkers-market/request-sample
Based on segmentation by application, biomarker market includes diagnostics development, drug discovery and
development, personalized medicine, DNA fingerprinting, ecotoxicology, forensics and disease risk assessment. Based
on segmentation by indication, the biomarkers market includes cancer, cardiovascular disorders, neurological
disorders, immunological disorders, renal disorders, urinal diseases and tuberculosis.
Geographically, biomarker market spans North America, Latin America, Europe, Asia-Pacific, Middle-East and Africa.
North America dominates the global market owing to rise in R&D spending for biomarker R&D and growth in
technological infrastructure are some growth factors for market growth in North America. APAC market is also
expected to gain a positive CAGR growth in the forthcoming period owing to rise in use of biomarkers for diagnostic
purpose, rise in incidences of chronic disease and rise in outsourcing of pharmaceutical R&D activities. The key players
in the biomarkers market include QIAGEN N.V., PerkinElmer Inc, Merck Millipore, Bio-Rad Laboratories Inc and Enzo
Biochem Inc.
Market Segment:
This report focuses on the global top players, covered
• QIAGEN N.V. (Netherlands)
• PerkinElmer, Inc. (U.S.)
• Merck Millipore (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• Enzo Biochem, Inc. (U.S.)